1428 10 (Farxiga 10 mg)
Generic Name: dapagliflozin
Pill with imprint 1428 10 is Yellow, Four-sided and has been identified as Farxiga 10 mg. It is supplied by Bristol-Myers Squibb Company.
Farxiga is used in the treatment of diabetes, type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1428 10
Farxiga
- Generic Name:
- dapagliflozin
- Imprint:
- 1428 10
- Strength:
- 10 mg
- Color:
- Yellow
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- SGLT-2 inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb Company
- National Drug Code (NDC):
- 00003-1428
More about Farxiga (dapagliflozin)
- Farxiga Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 81 Reviews
- Drug class: SGLT-2 inhibitors
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
